{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review

Purpose of Activity

To provide information on the use of dexmedetomidine therapy to treat alcohol withdrawal syndrome (AWS).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Examine issues related to alcohol abuse and AWS.
  2. Evaluate results from studies on the use of dexmedetomidine to treat AWS.
Price: $17.95


  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Test Code: JAN1017
Published: Oct/Dec 2017
Expires: 12/6/2019
Passing Score: 13/18 (72%)
Authors: Tarenne A. Ferenchak, BA, BSN, MSN, RN